Dana-Farber-Led Studies in Sickle Cell Disease, Waldenstrom's, Follicular and Mantle Cell Lymphomas, and MDS Presented at ASH 2025
November 24, 2025
November 24, 2025
BOSTON, Massachusetts, Nov. 24 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:
* * *
Dana-Farber-Led Studies in Sickle Cell Disease, Waldenstrom's, Follicular and Mantle Cell Lymphomas, and MDS Presented at ASH 2025
*
Dana-Farber Cancer Institute will present more than 120 oral and poster presentations at the 67th American Society for Hematology Annual Meeting and Exposition in Orlando, Florid . . .
* * *
Dana-Farber-Led Studies in Sickle Cell Disease, Waldenstrom's, Follicular and Mantle Cell Lymphomas, and MDS Presented at ASH 2025
*
Dana-Farber Cancer Institute will present more than 120 oral and poster presentations at the 67th American Society for Hematology Annual Meeting and Exposition in Orlando, Florid . . .
